The company has a good ESG score relative to its sector, according to MSCI.
Highlights: Walgreens Boots Alliance, Inc.
The stock, which is currently worth 2025 to 0.1 times its sales, is clearly overvalued in comparison with peers.
The company's share price in relation to its net book value makes it look relatively cheap.
The company is one of the best yield companies with high dividend expectations.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analyst opinion has improved significantly over the past four months.
Weaknesses: Walgreens Boots Alliance, Inc.
With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Low profitability weakens the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
The company's earnings releases usually do not meet expectations.